Literature DB >> 3030502

Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.

R C Silvia, G R Slizgi, J H Ludens, A H Tang.   

Abstract

U-50488 is a specific kappa opioid agonist which produces in rats water diuresis resulting in an elevation of plasma osmolarity. Pretreatment with U-50488H (the methanesulfonate salt) in Fisher rats prior to 4 h of bilateral carotid occlusion prevented the development of edema in the forebrain, and the effect was greater than that from pentobarbital anesthesia. An additional injection of an antidiuretic hormone which prevented the plasma hyperosmolarity also significantly reduced the anticerebral edemic effects of U-50488H. The plasma osmotic effect, however, may not completely account for the ischemic protection produced by U-50488H.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030502     DOI: 10.1016/0006-8993(87)90121-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

2.  Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

Authors:  P J Birch; H Rogers; A G Hayes; N J Hayward; M B Tyers; D I Scopes; A Naylor; D B Judd
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

3.  Kappa Opioid Receptor Agonist and Brain Ischemia.

Authors:  Chen Chunhua; Xi Chunhua; Sugita Megumi; Liu Renyu
Journal:  Transl Perioper Pain Med       Date:  2014

Review 4.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

5.  κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway.

Authors:  Jianing Fan; Long Li; Pengxia Qu; Yugang Diao; Yingjie Sun
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 6.  Spinocerebellar ataxia type 23 (SCA23): a review.

Authors:  Fan Wu; Xu Wang; Xiaohan Li; Huidi Teng; Tao Tian; Jing Bai
Journal:  J Neurol       Date:  2020-11-11       Impact factor: 6.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.